Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
Next-generation cancer therapy shows early promise as treatment candidate for glioblastoma

Next-generation cancer therapy shows early promise as treatment candidate for glioblastoma

Multi-center research initiative aims to improve glioblastoma patient outcomes

Multi-center research initiative aims to improve glioblastoma patient outcomes

Study challenges assumptions about testosterone’s role in brain cancer

Study challenges assumptions about testosterone’s role in brain cancer

Testosterone may help limit brain tumor growth in men

Testosterone may help limit brain tumor growth in men

Extracellular vesicles from T cells enhance tumor immune response

Extracellular vesicles from T cells enhance tumor immune response

New strategy boosts natural killer cells to fight cancer

New strategy boosts natural killer cells to fight cancer

Hyperbaric oxygen therapy shows dual effects in glioblastoma treatment

Hyperbaric oxygen therapy shows dual effects in glioblastoma treatment

New molecule weakens glioblastoma and enhances immune response

New molecule weakens glioblastoma and enhances immune response

Microglia actively shape glioblastoma growth and tumor spread

Microglia actively shape glioblastoma growth and tumor spread

Researchers discover how cell membrane composition drives cancer proliferation

Researchers discover how cell membrane composition drives cancer proliferation

Pseudogene lncRNAs regulate cancer stem cell behavior and signaling

Pseudogene lncRNAs regulate cancer stem cell behavior and signaling

Newly developed smart molecules offer a safer and more precise approach to cancer care

Newly developed smart molecules offer a safer and more precise approach to cancer care

Blocking nitric oxide suppresses tumor growth in aggressive pediatric neuroblastoma

Blocking nitric oxide suppresses tumor growth in aggressive pediatric neuroblastoma

Mayo Clinic researchers develop experimental nanotherapy to treat aggressive brain tumors

Mayo Clinic researchers develop experimental nanotherapy to treat aggressive brain tumors

NCCN grants funding to five oncology leaders of the future

NCCN grants funding to five oncology leaders of the future

Study introduces biomarker to characterize aggressiveness of brain tumors

Study introduces biomarker to characterize aggressiveness of brain tumors

Can AI chatbots help brain tumor patients understand their care?

Can AI chatbots help brain tumor patients understand their care?

New mechanism driving glioblastoma growth offers potential treatment targets

New mechanism driving glioblastoma growth offers potential treatment targets

Blocking fructose metabolism may improve brain tumor immunotherapy response

Blocking fructose metabolism may improve brain tumor immunotherapy response

STING agonists exert potent antitumor effects against nervous system tumors

STING agonists exert potent antitumor effects against nervous system tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.